Maven Securities »

Nurix Therapeutics shares owned by Maven Securities

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Maven Securities from 13F filings

Historical chart of Maven Securities investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Maven Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Maven Securities

Quarter filed Position value Share count Share price at filing
2025-12-31 $569k 30k 18.97

More positions owned by Maven Securities

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Call Call Option
Invesco Qqq Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Select Sector Spdr Tr Put Put Option
Apple Put Put Option
Select Sector Spdr Tr Put Put Option
Newmont Corp Put Put Option
Select Sector Spdr Tr Call Call Option
Unitedhealth Group Put Put Option
Nvidia Corporation Put Put Option
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon Call Call Option

View all positions for Maven Securities

Top funds holding Nurix Therapeutics

FMR
BlackRock
Deep Track Capital
Vanguard Group
Vestal Point Capital
Baker Bros. Advisors
Redmile Group
State Street Corporation
Pictet Asset Management Holding SA
Point72 Asset Management
Deutsche Bank Aktiengesellschaft
Rubric Capital Management
Geode Capital Management
Commodore Capital
Braidwell

View all funds holding Nurix Therapeutics